KBTBD13
protein-codingkelch repeat and BTB domain containing 13, the group of BTB domain containing
Gene summary
The gene belongs to a family of genes encoding proteins containing a BTB domain and several kelch repeats. The BTB domain functions as a protein-protein interaction module, which includes an ability to self-associate or to interact with non-BTB domain-containing proteins. The kelch motif typically occurs in groups of five to seven repeats, and has been found in proteins with diverse functions. Known functions of these family members include transcription regulation, ion channel tetramerization and gating, protein ubiquitination or degradation, and cytoskeleton regulation. The exact function of this family member has yet to be determined. [provided by RefSeq, Jun 2010]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~3.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0012237
Submitter: ClinGen
*KBTBD13* was first reported in relation to autosomal dominant nemaline myopathy 6 in 2010 (Sambuughin N, et al., 2010, PMID: 21109227). At least 12 unique missense variants, and 1 nonsense variant, have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data, segregation data, and experimental data. Variants in this gene have been reported in at least 16 probands in 8 publications (PMIDs: 31671076, 21109227, 31828823, 29382405, 30208948, 33693846, 33742414, 38968056). Variants in this gene segregated with disease in 49 additional family members. This gene-disease association is supported by its enhanced expression in skeletal muscle (PMID: 21109227), its role in relaxation of skeletal muscle where it interacts with actin (PMID: 31671076), and a knock-in mouse model which recapitulated human disease (PMID: 31671076).In summary, *KBTBD13* is definitively associated with autosomal dominant nemaline myopathy 6. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This gene-disease pair was originally evaluated by the CM GCEP on 06/22/2020. It was reevaluated on 01/21/2025. As a result of this reevaluation new genetic evidence (PMIDs:33693846, 33742414, 38968056) was identified and the classification increased from Moderate to Definitive.
Inheritance Pattern: AR
Disease ID:MONDO:0020127
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0012237
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0015738
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0012237
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0012237
Submitter: G2P
Inheritance Pattern: Unknown
Disease ID:MONDO:0012237
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0012237
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Musculoskeletal
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to KBTBD13 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001101362.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 35 | 145 | 3 | 183 | ||
| missense | 1 | 3 | 368 | 81 | 11 | 464 |
| nonsense | 15 | 1 | 16 | |||
| start loss | 1 | 2 | 3 | |||
| frameshift | 1 | 30 | 5 | 1 | 37 | |
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 1 | 4 | 449 | 234 | 15 | 703 |
Highest pathogenic variant AF is 0.0000044128615
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001094832.1 | 1 | MANE Select | |
| Ensembl | ENSP00000388723.2 | 1 | MANE Select |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Post-translational protein modification
- Metabolism of proteins
- Immune System
- Adaptive Immune System
- Antigen processing: Ubiquitination & Proteasome degradation
Biological Process
- protein ubiquitination
- post-translational protein modification
Cellular Component
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000432196
- Coding exons
- 1
- Length
- 3123
- Individuals with no LoFs
- 0
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 0
- Defined
- 0
- p
- 0.00
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.587 | 307 | 279 | 1.10 | 0.0000220 | 2765 |
| Missense (PolyPhen) | 94 | 92.834 | 1.0126 | 1011 | ||
| Synonymous | -1.44 | 168 | 146 | 1.15 | 0.0000135 | 997 |
| Loss of Function | -0.915 | 13 | 9.89 | 1.31 | 5.12e-7 | 99 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin ligase complex. {ECO:0000269|PubMed:22542517}.;
- Disease
- DISEASE: Nemaline myopathy 6 (NEM6) [MIM:609273]: A form of nemaline myopathy characterized by childhood onset of slowly progressive proximal muscle weakness, exercise intolerance, and slow movements with stiff muscles. Patients are unable to run or correct themselves from falling over. {ECO:0000269|PubMed:21109227}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.114
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |